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Advancers in Optical Imaging in Cancer 
Research – Part 2
www.tcrt.org
TCRT special section focusing on four articles to advance optical imaging which 
focuses on the prostate, breast, and fluorescence tumor markers for less invasive 
cancer diagnosis using light. Some of the articles touch upon the use of hypoxia in 
cancer tumors are discussed as a native bio marker advancing the ideas of Nobel 
Laureate Otto Warburg postulated in 1924, commonly called the Warburg effect.
The articles are:
Photonic Finger Near Infrared Imager for Screening Prostate Cancer focus 
on a portable rectal NIR imaging optical fiber based unit to detect prostate tumors 
using 3D optical tomography reconstructive algorithm called OPTICA.
Transrectal ultrasound-integrated spectral optical tomography of hypoxia 
progression of a regressing tumor in canine prostate focus a NIR optical 
tomography combined with ultrasound to monitor changes of oxi-hemoglobin and 
deoxi-hemoglobin in canine prostate.
Monitoring the response to primary therapy for Breast Cancer using Three 
Dimensional Time-Resolved Optical Mammography focus on hypoxia in tumors 
as a marker of cancer using hemoglobin absorption changes in NIR.
Using In Vivo Fluorescence imaging to Personalize Image and Treat Par-
adigm in Cancer Diagnostics and Therapy focus on drugs targeting specific 
tumors receptors as smart tumor markers for noninvasive fluorescence imaging 
modalities.
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